SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Ondas, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in West Palm Beach, FL.

Ondas Inc.

Ondas Inc

Ondas launch of Regna AI, a defense-focused sovereign-AI venture powered by Palantir, is driving attention, with bulls viewing it as an expansion beyond drone hardware into AI and software. Others question its near-term financial impact and point to weak price action, dilution concerns, and short-selling pressure despite the announcement.

Cerebras Systems, Inc. engages in the designing and provision of processors for artificial intelligence (AI) training and inference. Its products include inference, Wafer Scale Engine, AI supercomputers, AI model services, cloud, systems, and processors. The company was founded by Sean Lie, Andrew D. Feldman, Gary Lauterbach, Michael James, and Jean Philippe Fricker in 2015 and is headquartered in Sunnyvale, CA.

Cerebras Systems Inc - Ordinary Shares - Class A

Cerebras Systems Inc

Reports that OpenAI is using Nvidia GPUs rather than Cerebras hardware for a model feature have put Cerebrass relationship with a major customer under scrutiny and fueled a sharp selloff. Traders debate whether the report signals a meaningful shift or is overblown, while an approaching insider-share unlock adds to concerns about potential selling pressure.

Snap, Inc. is a technology company, which engages in the provision of a visual messaging application that was created to help people communicate through short videos and images. The company was founded by Frank Reginald Brown IV, Evan Thomas Spiegel, and Robert C. Murphy in 2010 and is headquartered in Santa Monica, CA.

Snap Inc - Ordinary Shares - Class A

Snap Inc

Snaps recent rally and technical breakout, accompanied by unusually heavy call buying and reports of a large options trade, are driving attention; traders are speculating about further momentum or a short squeeze ahead of earnings. Bulls are celebrating the move, while skeptics warn that past rallies have faded and question the companys outlook and management.

SoFi Technologies, Inc. is a financial service platform, which engages in the provision of student loan refinancing options to the private student loan market. It operates through the following segments: Lending, Technology Platform, and Financial Services. The Lending segment offers personal loans, student loans, home loan products, and related servicing activities. The Technology Platform segment focuses on technology products and solutions revenue. The Financial Services segment includes the SoFi Money product, SoFi Invest product, SoFi Credit Card product, SoFi Relay personal finance management product, and other financial services. The company was founded in April 2011 and is headquartered in San Francisco, CA.

SoFi Technologies Inc

A bearish analyst downgrade is drawing attention amid SoFis prolonged share-price slide toward its 52-week lows, with traders also watching upcoming earnings and guidance. Bulls point to continued business growth and blame short-selling or analyst timing, while bears cite high rates, valuation and credit risks, and dilution concerns.

JasmyCoin is based on the ERC 20 standard. The token can also be used by an unspecified number of individuals and businesses to transfer tokens using digital devices as proof of value exchange or payment for services. By not limiting its usability, the token can have a wide range of purposes.

JasmyCoin

Traders are focused on a reported burst of JasmyChain transactions, including activity using JASMY for gas, which bullish holders see as evidence of growing network use; skeptics question whether it signals meaningful adoption. Exchange delisting and trading-pair removal concerns, alongside JASMYs weak price performance, remain a bearish counterpoint.

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

IREN Limited

A report identifying Anthropic as the likely customer behind IRENs previously disclosed multiyear AI-cloud contract is driving attention, though neither company has confirmed the deal or disclosed its terms. Traders are split between viewing the report as validation of IRENs AI-infrastructure pivot and seeing limited upside without confirmation or evidence of incremental business; the initial rally faded amid broader pressure on data-center stocks.

Red Cat Holdings, Inc. provides products, services and solutions to the drone industry. It also engages in the provision of distributed data storage, analytics and services for the drone industry.The firm product include Dronebox, which is a blockchain technology that records, stores and analyzes flight data and information from a drone. It operates through the Enterprise Segment. The Enterprise Segment will focus on developing a hardware enabled software platform of services and solutions to government and commercial enterprises and the military. The company was founded by Jeffrey M. Thompson in February 1984 and is headquartered in San Juan, Puerto Rico.

Red Cat Holdings Inc

Red Cats AUSA launch of its unified Red Cat Aerial division and TRICHON drone is drawing attention, but many traders view it as product and branding news without concrete sales or purchase orders. The community is broadly frustrated by the share-price decline and managements lack of disclosed contract wins, while some bulls continue to cite longer-term defense-market potential.

Shopify, Inc. is a global commerce company that provides essential internet infrastructure for commerce, offering trusted tools to start, scale, market, and run a retail business of any size. The Company's software enables merchants to run their business across all of their sales channels, including web and mobile storefronts, physical retail locations, social media storefronts and marketplaces. The Shopify platform provides merchants with a single view of their business across all of their sales channels and enables them to manage products and inventory, process orders and payments, fulfill and ship orders, build customer relationships, source products, leverage analytics and reporting and access financing, all from one integrated back office. The company was founded on September 28, 2004 and is headquartered in Ottawa, Canada.

Shopify Inc - Ordinary Shares - Class A (Sub Voting)

Shopify Inc

Shopify is rallying toward record highs, with traders linking renewed interest to its Meta Muse/Shop Pay integration and broader optimism about AI-driven, agentic commerce. Bulls are celebrating the breakout and persistent dip-buying, while others call the move overextended and expect resistance or profit-taking.

USA Rare Earth, Inc. is a domestic supplier of rare earth magnets and heavy rare earth elements. It develops a vertically integrated domestic supply chain for rare earth element magnet production, with a facility in Stillwater and mining rights to the Round Top heavy rare earth and critical minerals deposit in West Texas. The company was founded in May 2019 and is headquartered in Stillwater, OK.

USA Rare Earth Inc. - Ordinary Shares - Class A

USA Rare Earth Inc

USA Rare Earth is drawing attention amid a steep, sustained selloff, with traders focused on potential share dilution and resale-registration overhang, alongside weakness across rare-earth stocks. Some investors blame short selling, while bulls argue the companys U.S. supply-chain role and government backing support the longer-term case.

Core Scientific, Inc. engages in the business of operating a purpose-built facility for digital asset mining and provision of blockchain infrastructure, software solutions, and services. It operates under the Mining and Hosting segments. The Mining segment focuses on bitcoin mining for the company's own account. The Hosting segment includes blockchain infrastructure and third-party hosting business. The company was founded by Michael Jeffrey Levitt and Darin Feinstein on December 13, 2017 and is headquartered in Dover, DE.

Core Scientific Inc - Ordinary Shares - New

Core Scientific Inc

CORZ is drawing attention amid broad selling across Bitcoin-miner and AI-data-center stocks, which traders attribute to macro pressure, higher rates and concerns about AI demand. Bulls view the pullback as sector-driven and point to its AI/HPC contracts and infrastructure pivot, while bearish traders remain wary of execution and the weak price action.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Why Did MRNA, HUM, LITE Stocks Surge To 52-Week Highs Last Week?

Modernas surge is being tied to the planned NIH cancer-vaccine initiative and optimism around its Phase 3 personalized melanoma vaccine with Merck, with Nasdaq-100 inclusion also cited as a source of index-fund buying. Traders are divided between bullish momentum and short-squeeze arguments and concerns that the rally is overextended and supported by temporary flows rather than near-term fundamentals.

After a rally tied to reports of a planned NIH-backed cancer-vaccine initiative, the pullback appears to reflect profit-taking and valuation concerns. No new company-specific negative catalyst is clearly supported.

Vaccine Stocks Rally on Reports of U.S.-led Push for Cancer Vaccines

MRNA, BNTX and NVAX shares rally after reports of a planned NIH-backed initiative to accelerate personalized cancer vaccines and expand research funding.

Why Did MRNA, HUM, LITE Stocks Surge To 52-Week Highs Last Week? 

Equity

The rallies highlighted growth opportunities across biotechnology, health insurance and optical technology.


Moderna Now Trades 61% Above Wall Street's Average Price Target. Should You Sell?

Key PointsInvestors turned away from Moderna in recent years as its blockbuster coronavirus vaccine saw declining demand...

BNTX, NVAX, MRNA Lead Vaccine Rally After Report Of An NIH Cancer-Vaccine Push 

National Cancer Institute’s director, Dr. Anthony Letai, wants a national effort behind the vaccines, The New York Times reported on Friday.


S&P 500, Nasdaq 100, Dow End Week Higher With Traders Eyeing Earnings Season — MSFT, NFLX, SPCX, ASTS In Focus

Wall Street’s biggest banks, including JPMorgan, Morgan Stanley, and Wells Fargo, will report earnings next week.

MRNA Stock Sets New 52-Week High As Nasdaq-100 Reentry Meets NIH Cancer-Vaccine Push

Moderna shares on Friday were driven by multiple catalysts, including a Nasdaq-100 entry, a New York Times report on a planned NIH-backed cancer-vaccine push and a price target hike. 

Moderna Stock Hits New 52-Week High: What's Happening?

Moderna shares are rising Friday to a fresh 52-week high. The stock enters the Nasdaq-100 Index. Here's what you should know.read more...

Moderna's Nasdaq-100 Entry: What Does It Mean for the Stock?

MRNA's Nasdaq-100 entry follows a 566% stock surge and stronger cancer therapy prospects, potentially boosting demand from index-tracking funds.

Axsome Therapeutics vs. Moderna: Which Biotech Stock Is a Better Buy in 2026?

Key PointsAxsome Therapeutics is seeing massive revenue growth as it expands its footprint in the central nervous system treatment market...

Tempus AI Doubles Down On Moderna and Merck Cancer Vaccine Infrastructure

Tempus AI expands its collaboration with Moderna and Merck to support sample collection and NGS services for intismeran autogene and Keytruda.read more...

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Neutral Sentiment

$CMPS

$SOUN

$MRNA

$LCID

Compass Pathways ($CMPS), SoundHoundAI ($SOUN), Moderna ($MRNA), and Lucid Group ($LCID) are four of the most searched and talked-about stocks among retail investors this morning. Which are you most bullish? Drop your reasoning in the comments.

Which of these trending stocks are you most bullish on for the next 5 years - $CMPS, $SOUN, $MRNA, or $LCID?

Stocktwits

COMPASS Pathways

SoundHound AI Inc

Lucid Group Inc

Which of these trending stocks are you most bullish on for the next 5 years - 

Stocktwits Polls

Forced buying by passive funds following Moderna's addition to the Nasdaq-100 fueled a sharp 14% single-day price surge.

Optimism surrounding a NIH-backed public-private partnership to fast-track cancer vaccine development has traders buzzing about potential clinical catalysts.

A fierce battle rages between momentum traders betting on scientific breakthroughs and bears citing deep net losses and astronomical 40x sales multiples.

Bearish traders betting on a post-catalyst pullback are getting caught in intense short squeezes as the stock defies negative analyst price targets.

Feed

News

Sentiment

Earnings

Fundamentals

Info

MRNA News